Bioventix

Bioventix was founded in 2003 as a biotechnology company specializing in the production and supply of high-affinity sheep monoclonal antibodies (SMA) for immunoassay diagnostics. The company focuses on the fields of clinical diagnostics and drug abuse testing. Its strategy is to identify new or existing commercial assays where antibodies are either already used or may be needed, with room for improvement. The company aims to provide customers with high-quality SMAs to address the shortcomings of other antibodies.